本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Neurosense Therapeutics Ltd

1.22
-0.0421-3.34%
盤後1.220.00000.00%17:38 EDT
成交量:24.58萬
成交額:30.43萬
市值:2,921.58萬
市盈率:-2.22
高:1.36
開:1.34
低:1.18
收:1.26
資料載入中...
2023/03/22

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/26

SEC問詢函

CORRESP [Cover] - Correspondence
2022/04/14

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/02

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/12/30

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/23

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/20

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/06

SEC問詢函

CORRESP [Cover] - Correspondence
2021/12/06

SEC問詢函

CORRESP [Cover] - Correspondence
2021/12/06

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/12/06

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/11/19

SEC問詢函

CORRESP [Cover] - Correspondence
2021/11/19

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/11/10

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/11/10

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/11/04

SEC問詢函

CORRESP [Cover] - Correspondence
2021/11/01

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers